12th Apr 2005 09:13
Sinclair Pharma PLC12 April 2005 Sinclair Pharma plc ("Sinclair" or the "Company") The Company received notification on 11 April 2005 that FMR Corp ("FMR"), parentholding company of Fidelity Management & Research Company ("FMRCO") and FidelityInternational Limited ("FIL"), parent holding company for various direct andindirect and indirect subsidiaries, including Fidelity Investment Services Ltd.("FISL"), are together interested in a total of 6,364,385 ordinary shares in theCompany, representing approximately 11.33 per cent. of the Company's issuedshare capital. The details of the holding are as follows: Shares held Management company Nominee / Registered name 282,669 FIJ Brown Brothers Harriman and Co 3,412,678 FIL Brown Bros Harrimn Ltd. LUX 234,143 FIL State STR BK and TR Co LNDN 920,980 FISL JP Morgan, Bournmouth 1,106,758 FMRCO Mellon Bank N.A. 245,370 FPM Bank of New York Brussels 30,406 FPM Clydesdale Bank Plc 44,063 FPM Mellon Bank 23,984 FPM Northern Trust London 63,334 FPM State STR BK and TR Co LNDN 6,364,385 Grand Total ordinary shares This notifiable interest also comprises the notifiable interest of Mr Edward C.Johnson 3rd, a principal shareholder of FMR and FIL. The notifiable interests include interests held on behalf of authorised unittrust schemes in the UK, notwithstanding the exemption from reporting pursuantto Section 209 (1)(h) of the Companies Act 1985. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma